Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Padula

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Arthritis and Rheumatism|February 13, 2002
The HLA-B*2709 subtype confers susceptibility to spondylarthropathyIgnazio Olivieri, Giovanni Ciancio, Angela Padula, et al.
The Journal of Rheumatology|April 3, 2003
Treatment of refractory polymyalgia rheumatica with infliximab: a pilot studyCarlo Salvarani, Fabrizio Cantini, Laura Niccoli, et al.
Clinical Rheumatology|June 5, 2017
Vitamin D deficiency in systemic sclerosis: a possible role of subclinical liver fibrosis? Retrospective analysis from an Italian cohortFrancesco Ursini, Salvatore D'Angelo, Angela Padula, et al.
Arthritis and Rheumatism|August 12, 2003
Efficacy of infliximab in resistant psoriatic arthritisCarlo Salvarani, Fabrizio Cantini, Ignazio Olivieri, et al.
Joint Bone Spine|September 14, 2016
Retrospective analysis of type 2 diabetes prevalence in a systemic sclerosis cohort from southern Italy: Comment on "Reduced incidence of Type 1 diabetes and Type 2 diabetes in systemic sclerosis: A nationwide cohort study" by Tseng et al., Joint Bone Spine 2016;83:307-13Francesco Ursini, Salvatore D'Angelo, Angela Padula, et al.
Clinical and Experimental Rheumatology|February 14, 2012
Low frequency of axial involvement in southern Italian Caucasian children with HLA-B27 positive juvenile onset undifferentiated spondyloarthritisIgnazio Olivieri, Maria Stefania Cutro, Salvatore D'Angelo, et al.
Frontiers in Medicine|December 30, 2021
Empowering Patients in the Therapeutic Decision-Making Process: A Glance Into Behçet's SyndromeDiana Marinello, Federica Di Cianni, Alessandra Del Bianco, et al.
Leukemia & Lymphoma|April 4, 2017
Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patientsGiovanni D'Arena, Vittorio Simeon, Luca Laurenti, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 12, 2021
Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE ProjectGianluca Trifirò, Valentina Isgrò, Ylenia Ingrasciotta, et al.
Journal of Autoimmunity|January 14, 2020
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictorsLuca Quartuccio, Milena Bond, Miriam Isola, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Arthritis and Rheumatism|February 13, 2002
The HLA-B*2709 subtype confers susceptibility to spondylarthropathyIgnazio Olivieri, Giovanni Ciancio, Angela Padula, et al.
The Journal of Rheumatology|April 3, 2003
Treatment of refractory polymyalgia rheumatica with infliximab: a pilot studyCarlo Salvarani, Fabrizio Cantini, Laura Niccoli, et al.
Clinical Rheumatology|June 5, 2017
Vitamin D deficiency in systemic sclerosis: a possible role of subclinical liver fibrosis? Retrospective analysis from an Italian cohortFrancesco Ursini, Salvatore D'Angelo, Angela Padula, et al.
Arthritis and Rheumatism|August 12, 2003
Efficacy of infliximab in resistant psoriatic arthritisCarlo Salvarani, Fabrizio Cantini, Ignazio Olivieri, et al.
Joint Bone Spine|September 14, 2016
Retrospective analysis of type 2 diabetes prevalence in a systemic sclerosis cohort from southern Italy: Comment on "Reduced incidence of Type 1 diabetes and Type 2 diabetes in systemic sclerosis: A nationwide cohort study" by Tseng et al., Joint Bone Spine 2016;83:307-13Francesco Ursini, Salvatore D'Angelo, Angela Padula, et al.
Clinical and Experimental Rheumatology|February 14, 2012
Low frequency of axial involvement in southern Italian Caucasian children with HLA-B27 positive juvenile onset undifferentiated spondyloarthritisIgnazio Olivieri, Maria Stefania Cutro, Salvatore D'Angelo, et al.
Frontiers in Medicine|December 30, 2021
Empowering Patients in the Therapeutic Decision-Making Process: A Glance Into Behçet's SyndromeDiana Marinello, Federica Di Cianni, Alessandra Del Bianco, et al.
Leukemia & Lymphoma|April 4, 2017
Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patientsGiovanni D'Arena, Vittorio Simeon, Luca Laurenti, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 12, 2021
Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE ProjectGianluca Trifirò, Valentina Isgrò, Ylenia Ingrasciotta, et al.
Journal of Autoimmunity|January 14, 2020
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictorsLuca Quartuccio, Milena Bond, Miriam Isola, et al.
Pageof 8